Neurocrine Biosciences (FRA:NB3) Other Long-Term Liabilities : €111 Mil (As of Mar. 2024)

View and export this data going back to 1996. Start your Free Trial

What is Neurocrine Biosciences Other Long-Term Liabilities?

Neurocrine Biosciences's other long-term liabilities for the quarter that ended in Mar. 2024 was €111 Mil.

Neurocrine Biosciences's quarterly other long-term liabilities increased from Sep. 2023 (€64 Mil) to Dec. 2023 (€97 Mil) and increased from Dec. 2023 (€97 Mil) to Mar. 2024 (€111 Mil).

Neurocrine Biosciences's annual other long-term liabilities increased from Dec. 2021 (€11 Mil) to Dec. 2022 (€28 Mil) and increased from Dec. 2022 (€28 Mil) to Dec. 2023 (€97 Mil).

Neurocrine Biosciences Other Long-Term Liabilities Historical Data

The historical data trend for Neurocrine Biosciences's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neurocrine Biosciences Other Long-Term Liabilities Chart

Neurocrine Biosciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long-Term Liabilities

Get a 7-Day Free Trial

Neurocrine Biosciences Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Long-Term Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Neurocrine Biosciences Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Neurocrine Biosciences Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Neurocrine Biosciences's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Neurocrine Biosciences (FRA:NB3) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Neurocrine Biosciences Inc (FRA:NB3) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

NBIX:USA N1BI34:Brazil

Address

12780 El Camino Real, San Diego, CA, USA, 92130

Website

https://www.neurocrine.com

Neurocrine Biosciences Inc is a research-based pharmaceutical company advancing drug candidates in the central nervous system and endocrine-related categories. The company's three late stage clinical programs are elagolix which is hormone releasing antagonist for women's health, opicapone which is an inhibitor for parkinson's patients, and ingrezza for tourette syndrome.

Neurocrine Biosciences (FRA:NB3) Headlines

No Headlines